今天港股创新药方向暴涨,创新药ETF霸屏涨幅榜,其中,恒生创新药ETF(520500)涨6.15%,位居今天涨幅榜第三。恒生创新药今年以来涨幅近30%,超过恒生科技的涨幅了...创新药的大涨源于信达生物的业绩超预期,今天信达生物大涨超17.41%。公司24年总收入达94.22亿元,同比增长51.8%,其中产品收入82.28亿元(+43.6%),授权费收入11亿元(较2023年的4.47亿元大幅增长...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.